Public COA audit

Triple Agonist · Retatrutide

Audited July 28, 2026

Consistent with a legitimate COA

Document structure and test panels align with what we expect from authentic lab reports.

Legitimacy
95
Confidence
92%
Panels
5/7
Purity (printed)
99.9%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR26063XAG15-01-GRAY
Identity method
HPLC-RTM (retention time comparison with reference standard)
Sample date
2026-07-06
Issue date
2026-07-21

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed (Retatrutide)

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.90%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    As, Cd, Pb, Hg: Not Detected; Cr: 0.964 ppm

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    0.103 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.90% purity by HPLC with conformity testing across 3 samples (mean 99.90%, std dev 0.0000%), all passing ≥95.0% specification. This is normal for research-grade peptides.

  • Identity confirmed

    Triple Agonist (Retatrutide) confirmed by HPLC retention time comparison with reference standard. Includes fentanyl screen (not detected).

  • Batch information complete

    Lot CR26063XAG15-01-GRAY, COA-2026-CRIQ31, Accession ACC-2026-8206. Net peptide content 15.8 mg (labeled 15 mg).

  • Dates consistent

    Received 2026-07-06, analyzed and issued 2026-07-21. All dates are on or before today (2026-07-28) and logically sequenced.

  • Lab credentials present

    ILS Laboratories, San Diego CA, ISO/IEC 17025 accredited. Signed by Dr. Greg Kalyuzhny (Lab Director). Verification URL and access code provided.

  • Comprehensive testing

    Six panels present: purity (HPLC), identity (HPLC-RTM), heavy metals (ICP-MS), endotoxin (USP <85>), sterility (PCR), plus fentanyl screen. All tests passed. Microbial and residual solvent/water panels not included.

  • Professional presentation

    Well-formatted 2-page COA with chromatogram, conformity testing table, detailed methodology notes, QR code for verification, and ISO accreditation statement.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.